Effects of systemically administered NT-3 on sensory neuron loss and nestin expression following axotomy

J Comp Neurol. 2005 Feb 21;482(4):320-32. doi: 10.1002/cne.20400.

Abstract

Previous work has shown that administration of the neurotrophin NT-3 intrathecally or to the proximal stump can prevent axotomy-induced sensory neuron loss and that NT-3 can stimulate sensory neuron differentiation in vitro. We have examined the effect of axotomy and systemic NT-3 administration on neuronal loss, apoptosis (defined by morphology and activated caspase-3 immunoreactivity), and nestin expression (a protein expressed by neuronal precursor cells) in dorsal root ganglia (DRG) following axotomy of the adult rat sciatic nerve. Systemic administration of 1.25 or 5 mg of NT-3 over 1 month had no effect on the incidence of apoptotic neurons but prevented the overall loss of neurons seen at 4 weeks in vehicle-treated animals. Nestin-immunoreactive neurons began to appear 2 weeks after sciatic transection in untreated animals and steadily increased in incidence over the next 6 weeks. NT-3 administration increased the number of nestin-immunoreactive neurons at 1 month by two- to threefold. Nestin-IR neurons had a mean diameter of 20.78 +/- 2.5 microm and expressed the neuronal markers neurofilament 200, betaIII-tubulin, protein gene product 9.5, growth associated protein 43, trkA, and calcitonin gene-related peptide. Our results suggest that the presence of nestin in DRG neurons after nerve injury is due to recent differentiation and that exogenous NT-3 may prevent neuron loss by stimulating this process, rather than preventing neuron death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Axotomy
  • Biomarkers
  • Caspase 3
  • Caspases / metabolism
  • Cell Count
  • Cell Differentiation / physiology
  • Cell Size
  • Cytoprotection / drug effects
  • Cytoprotection / physiology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Immunohistochemistry
  • Infusion Pumps, Implantable
  • Intermediate Filament Proteins / metabolism*
  • Male
  • Nerve Degeneration / drug therapy*
  • Nerve Degeneration / physiopathology
  • Nerve Degeneration / prevention & control*
  • Nerve Tissue Proteins / metabolism*
  • Nestin
  • Neurons, Afferent / cytology
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / metabolism*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Neurotrophin 3 / pharmacology*
  • Neurotrophin 3 / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Sciatic Neuropathy / drug therapy*
  • Sciatic Neuropathy / metabolism
  • Sciatic Neuropathy / physiopathology

Substances

  • Biomarkers
  • Intermediate Filament Proteins
  • Nerve Tissue Proteins
  • Nes protein, rat
  • Nestin
  • Neuroprotective Agents
  • Neurotrophin 3
  • Casp3 protein, rat
  • Caspase 3
  • Caspases